)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
Kymera Therapeutics (KYMR) investor relations material
Kymera Therapeutics TD Cowen Immunology and Inflammation Summit summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen Immunology and Inflammation Summit summary13 Nov, 2025
Platform and pipeline overview
Degrader platform enables targeting of high-priority, difficult-to-drug targets, with five programs advanced to the clinic in five years.
Focus has shifted toward building a best-in-class oral immunology pipeline, with STAT6 and IRF5 as flagship programs.
STAT6 program completed healthy volunteer study and phase 1B AD dosing, with data to be shared next month; phase 2B AD and asthma studies are underway or planned.
IRF5 program completed IND-enabling studies, moving into phase 1 early next year with data expected in the same year.
Cash runway extends into the second half of 2028, supporting key milestones for STAT6, IRF5, and new programs.
Clinical development and data translation
High-fidelity translation from healthy volunteers to patients is expected based on prior program experience.
Phase 1B aims to confirm translation of safety, PK, and PD (STAT6 degradation) in blood and skin, informing phase 2B dose selection.
STAT6 degrader achieves maximal blood degradation within 4–8 hours, with pathway inhibition kinetics similar to DUPI.
TARC reduction is used as a PD marker, with % reduction dependent on baseline levels; DUPI-like effects are anticipated.
EASI and TARC show moderate correlation; phase 1B aims for activity at day 28 comparable to DUPI's results.
Dose selection and trial design
Phase 2B dose selection is based on extensive phase 1A data, with phase 1B providing translation confirmation.
Three dose levels in phase 2B are designed to cover optimal, supermaximal, and submaximal degradation.
The same dose range will be tested in both AD and asthma phase 2B studies; final phase 3 dose may differ.
TARC/EASI interpretation for 1B AD data
Rationale for early 2B AD study initiation
Degrader vs. inhibitor for STAT6: Kymera's view?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Kymera Therapeutics earnings date
Jefferies London Healthcare Conference 202519 Nov, 2025
Next Kymera Therapeutics earnings date
Jefferies London Healthcare Conference 202519 Nov, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Kymera Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing targeted protein degradation therapies. The company’s proprietary platform aims to design small-molecule drugs that selectively degrade disease-causing proteins, offering a novel approach to treating conditions that have been difficult to address with traditional therapies. Kymera Therapeutics is engaged in research and development across various therapeutic areas, including oncology, immunology, and inflammation. The company is headquartered in Watertown, United States, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage